INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Public company

AMGNAMGEN INC

CIK 0000318154

EDGAR filingsOpen in network
Disclosed transactions8
Buys / sells3 / 4
Max Insider Score31
Connections29with evidence

AMGN · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
David J. TaylorRSelf
AMGNAMGEN INC
Purchase
BUY$1,001 – $15KSep 22, 2026Oct 1, 2026
traded Sep 22, 2026
+9dHOUSE PTR

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
  • ← Connected organizationevidence
    AMGEN INC. POLITICAL ACTION COMMITTEEFEC Form 1 connected organization: AMGEN INC. (curated map) · Nov 4, 2026
  • ← Disclosed trade inevidence
    David J. TaylorSale disclosed 2026-09-05 · Sep 5, 2026
  • ← Disclosed trade inevidence
    Sheldon WhitehouseTransaction disclosed 2026-09-02 · Sep 2, 2026
16
David J. TaylorRSelf
AMGNAMGEN INC
Sale
SELL
$1,001 – $15K
Aug 26, 2026
Sep 5, 2026
traded Aug 26, 2026
+10d
HOUSE PTR

Evidence

16
David J. TaylorRSelf
AMGNAMGEN INC
Sale
SELL$1,001 – $15KAug 26, 2026Sep 5, 2026
traded Aug 26, 2026
+10dHOUSE PTR

Evidence

14
Sheldon WhitehouseDSpouse
AMGNAMGEN INC
sell
sell$1,001 – $15KAug 12, 2026Sep 2, 2026
traded Aug 12, 2026
+21dSENATE PTR

Evidence

31
David J. TaylorRSelf
AMGNAMGEN INC
Purchase
BUY$1,001 – $15KJun 5, 2026Jun 12, 2026
traded Jun 5, 2026
+7dHOUSE PTR

Evidence

31
Maria Elvira SalazarRSelf
AMGNAMGEN INC
Sale
SELL$15K – $50KApr 17, 2026May 8, 2026
traded Apr 17, 2026
+21dHOUSE PTR

Evidence

28
Maria Elvira SalazarRSelf
AMGNAMGEN INC
Purchase
BUY$15K – $50KMar 24, 2026Apr 21, 2026
traded Mar 24, 2026
+28dHOUSE PTR

Evidence

20
David J. TaylorRSelf
AMGNAMGEN INC
Sale
SELL$1,001 – $15KFeb 26, 2026Mar 6, 2026
traded Feb 26, 2026
+8dHOUSE PTR

Evidence

  • ← Lobbied forevidence
    ALPINE GROUP PARTNERS, LLC.LDA Q2 2026 second quarter · Medicare/Medicaid, Taxation, Trade · Aug 26, 2026
  • ← Lobbied forevidence
    WASHINGTON ADVOCACY GROUPLDA 2T 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    SIGHTLINE ADVOCACY, LLCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    AVENUE SOLUTIONSLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    CAPITOL 6 ADVISORSLDA Q1Y 2026 first quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    PANNONE LOPES DEVEREAUX & O'GARA LLCLDA Q1 2026 first quarter · Pharmacy · Aug 26, 2026
  • ← Lobbied forevidence
    TARPLIN, DOWNS & YOUNG, LLCLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Budget/appropriations · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK HEALTH STRATEGIES, INC.LDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    MILLER STRATEGIES, LLCLDA Q1 2026 first quarter · Health issues, Medicare/Medicaid, Immigration · Aug 26, 2026
  • ← Lobbied forevidence
    WILLIAMS AND JENSEN, PLLCLDA Q2 2026 second quarter · Budget/appropriations, Labor, Copyright/patent, Health issues, Medicare/Medicaid, Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    TIBER CREEK GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    MICHAEL J. LAMOUREUXLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    THE NICKLES GROUP, LLCLDA Q1 2026 first quarter · Taxation, Medicare/Medicaid, Health issues, Copyright/patent · Aug 26, 2026
  • ← Lobbied forevidence
    CAPITOL TAX PARTNERS, LLPLDA Q1 2026 first quarter · Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    CAPITOL COUNSEL LLCLDA Q2 2026 second quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    THE MCMANUS GROUPLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    BGR GOVERNMENT AFFAIRSLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    TODD STRATEGY GROUPLDA Q1 2026 first quarter · Medicare/Medicaid, Health issues, Taxation · Aug 26, 2026
  • ← Lobbied forevidence
    JEFFREY J. KIMBELL & ASSOCIATES, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    MR. DAN CRIPPENLDA Q2Y 2026 second quarter · issues not listed · Aug 26, 2026
  • ← Lobbied forevidence
    AMGEN, INC.LDA Q2 2026 second quarter · Health issues, Medicare/Medicaid, Taxation, Copyright/patent, TAR · Aug 26, 2026
  • ← Lobbied forevidence
    FEDERAL HEALTH COUNSEL, LLCLDA Q1 2026 first quarter · Medicare/Medicaid · Aug 26, 2026
  • ← Lobbied forevidence
    HILLNORTH LLCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Lobbied forevidence
    EMPIRE CONSULTING GROUPLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • ← Disclosed trade inevidence
    Maria Elvira SalazarPurchase disclosed 2026-04-21 · Apr 21, 2026

    • Lobbying

    $6.76M reported · de-duplicated
    2026 Q2 $3.34M via firms2026 Q1 $3.42M via firms
    • MILLER STRATEGIES, LLC$60K2026 Q2 · posted Aug 26, 2026 · Immigration, Health issues, Medicare/Medicaid
    • WILLIAMS AND JENSEN, PLLC$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Taxation, Budget/appropriations, Labor, Copyright/patent
    • MICHAEL J. LAMOUREUX—2026 Q2 · posted Aug 26, 2026 · MED
    • EMPIRE CONSULTING GROUP$50K2026 Q2 · posted Aug 26, 2026 · Health issues
    • TARPLIN, DOWNS & YOUNG, LLC$60K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Budget/appropriations
    • TIBER CREEK GROUP$60K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
    • THE NICKLES GROUP, LLC$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues, Copyright/patent, Taxation, Trade
    • CAPITOL TAX PARTNERS, LLP$60K2026 Q2 · posted Aug 26, 2026 · Taxation
    • CAPITOL COUNSEL LLC$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid
    • THE MCMANUS GROUP$60K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid
    • CAPITOL 6 ADVISORS$60K2026 Q2 · posted Aug 26, 2026 ·
    • TIBER CREEK HEALTH STRATEGIES, INC.—2026 Q1 · posted Aug 26, 2026 ·

    Connected PAC contributions

    FEC · direct to members
    • Jon HustedR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
    • Jason SmithR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
    • Ashley MoodyR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
    • Scott H. PetersD$10KAMGEN INC. POLITICAL ACTION COMMITTEE
    • Brett GuthrieR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
    Margaret Wood HassanD
    $10K
    AMGEN INC. POLITICAL ACTION COMMITTEE
  • John CornynR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
  • Richard HudsonR$10KAMGEN INC. POLITICAL ACTION COMMITTEE
  • Pete RickettsR$9,000AMGEN INC. POLITICAL ACTION COMMITTEE
  • Steven HorsfordD$8,500AMGEN INC. POLITICAL ACTION COMMITTEE
  • Nathaniel MoranR$8,500AMGEN INC. POLITICAL ACTION COMMITTEE
  • H. Morgan GriffithR$7,500AMGEN INC. POLITICAL ACTION COMMITTEE